The Clinical Significance of HER2+ Breast Cancer and Opportunities for Improved Outcomes
ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatment After Recovery From Grade 1 ILD”
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
Login to view comments.
Click here to Login